BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 9370425)

  • 1. Meta-stability of the hemifusion intermediate induced by glycosylphosphatidylinositol-anchored influenza hemagglutinin.
    Nüssler F; Clague MJ; Herrmann A
    Biophys J; 1997 Nov; 73(5):2280-91. PubMed ID: 9370425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inner but not outer membrane leaflets control the transition from glycosylphosphatidylinositol-anchored influenza hemagglutinin-induced hemifusion to full fusion.
    Melikyan GB; Brener SA; Ok DC; Cohen FS
    J Cell Biol; 1997 Mar; 136(5):995-1005. PubMed ID: 9060465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPI-anchored influenza hemagglutinin induces hemifusion to both red blood cell and planar bilayer membranes.
    Melikyan GB; White JM; Cohen FS
    J Cell Biol; 1995 Nov; 131(3):679-91. PubMed ID: 7593189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The lipid-anchored ectodomain of influenza virus hemagglutinin (GPI-HA) is capable of inducing nonenlarging fusion pores.
    Markosyan RM; Cohen FS; Melikyan GB
    Mol Biol Cell; 2000 Apr; 11(4):1143-52. PubMed ID: 10749920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemifusion between cells expressing hemagglutinin of influenza virus and planar membranes can precede the formation of fusion pores that subsequently fully enlarge.
    Razinkov VI; Melikyan GB; Cohen FS
    Biophys J; 1999 Dec; 77(6):3144-51. PubMed ID: 10585935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiple local contact sites are induced by GPI-linked influenza hemagglutinin during hemifusion and flickering pore formation.
    Frolov VA; Cho MS; Bronk P; Reese TS; Zimmerberg J
    Traffic; 2000 Aug; 1(8):622-30. PubMed ID: 11208150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathway of membrane fusion catalyzed by influenza hemagglutinin: restriction of lipids, hemifusion, and lipidic fusion pore formation.
    Chernomordik LV; Frolov VA; Leikina E; Bronk P; Zimmerberg J
    J Cell Biol; 1998 Mar; 140(6):1369-82. PubMed ID: 9508770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transmembrane domain of influenza hemagglutinin exhibits a stringent length requirement to support the hemifusion to fusion transition.
    Armstrong RT; Kushnir AS; White JM
    J Cell Biol; 2000 Oct; 151(2):425-37. PubMed ID: 11038188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-anchored influenza hemagglutinin promotes hemifusion, not complete fusion.
    Kemble GW; Danieli T; White JM
    Cell; 1994 Jan; 76(2):383-91. PubMed ID: 8293471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-chain alcohols promote an early stage of membrane hemifusion.
    Chanturiya A; Leikina E; Zimmerberg J; Chernomordik LV
    Biophys J; 1999 Oct; 77(4):2035-45. PubMed ID: 10512823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fusion activity of transmembrane and cytoplasmic domain chimeras of the influenza virus glycoprotein hemagglutinin.
    Schroth-Diez B; Ponimaskin E; Reverey H; Schmidt MF; Herrmann A
    J Virol; 1998 Jan; 72(1):133-41. PubMed ID: 9420208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modification of the cytoplasmic domain of influenza virus hemagglutinin affects enlargement of the fusion pore.
    Kozerski C; Ponimaskin E; Schroth-Diez B; Schmidt MF; Herrmann A
    J Virol; 2000 Aug; 74(16):7529-37. PubMed ID: 10906206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of X31 influenza virus fusion on phosphatidylserine asymmetry in erythrocytes.
    Pak CC; Blumenthal R
    Biochim Biophys Acta; 1996 Jan; 1278(1):98-104. PubMed ID: 8611613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPI- and transmembrane-anchored influenza hemagglutinin differ in structure and receptor binding activity.
    Kemble GW; Henis YI; White JM
    J Cell Biol; 1993 Sep; 122(6):1253-65. PubMed ID: 8397215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary structure, orientation, oligomerization, and lipid interactions of the transmembrane domain of influenza hemagglutinin.
    Tatulian SA; Tamm LK
    Biochemistry; 2000 Jan; 39(3):496-507. PubMed ID: 10642174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetically differentiating influenza hemagglutinin fusion and hemifusion machines.
    Mittal A; Leikina E; Chernomordik LV; Bentz J
    Biophys J; 2003 Sep; 85(3):1713-24. PubMed ID: 12944286
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liposome composition effects on lipid mixing between cells expressing influenza virus hemagglutinin and bound liposomes.
    Bailey A; Zhukovsky M; Gliozzi A; Chernomordik LV
    Arch Biochem Biophys; 2005 Jul; 439(2):211-21. PubMed ID: 15963452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reevaluating herpes simplex virus hemifusion.
    Jackson JO; Longnecker R
    J Virol; 2010 Nov; 84(22):11814-21. PubMed ID: 20844038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversible merger of membranes at the early stage of influenza hemagglutinin-mediated fusion.
    Leikina E; Chernomordik LV
    Mol Biol Cell; 2000 Jul; 11(7):2359-71. PubMed ID: 10888674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A point mutation in the transmembrane domain of the hemagglutinin of influenza virus stabilizes a hemifusion intermediate that can transit to fusion.
    Melikyan GB; Markosyan RM; Roth MG; Cohen FS
    Mol Biol Cell; 2000 Nov; 11(11):3765-75. PubMed ID: 11071905
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.